Enrique A. Conterno
2017
In 2017, Enrique A. Conterno earned a total compensation of $8.6M as Senior Vice President and President, Lilly Diabetes and President, Lilly USA at Lilly Eli & Co, a 88% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $999,426 |
|---|---|
| Non-Equity Incentive Plan | $816,866 |
| Salary | $762,002 |
| Stock Awards | $6,000,000 |
| Other | $45,720 |
| Total | $8,624,014 |
Conterno received $6M in stock awards, accounting for 70% of the total pay in 2017.
Conterno also received $999.4K of change in pension value and nonqualified deferred compensation earnings, $816.9K in non-equity incentive plan, $762K in salary and $45.7K in other compensation.
Rankings
In 2017, Enrique A. Conterno's compensation ranked 833rd out of 14,666 executives tracked by ExecPay. In other words, Conterno earned more than 94.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 833 out of 14,666 | 94th |
Division Manufacturing | 280 out of 5,772 | 95th |
Major group Chemicals And Allied Products | 70 out of 2,075 | 97th |
Industry group Drugs | 50 out of 1,731 | 97th |
Industry Pharmaceutical Preparations | 41 out of 1,333 | 97th |
Source: SEC filing on March 22, 2019.
Conterno's colleagues
We found two more compensation records of executives who worked with Enrique A. Conterno at Lilly Eli & Co in 2017.